A Randomised, Double-Blind Placebo-Controlled, Multi-Centric Clinical Trial of Ultra-Diluted Mycobacterium tuberculosis Nosode (Emtact 30c) in the Management of Recurrent Upper and Lower Respiratory Tract Affections
Abstract:Introduction Due to the rising incidence of respiratory infections, numerous interventions are being tried as preventive/therapeutic alternatives. The Emtact 30c is a polyvalent nosode prepared from various strains of Mycobacterium tuberculosis organisms. The objective of this clinical trial was to investigate the efficacy of Emtact 30c by measuring the reduction in frequency, severity of episodes and relief in recurrent upper/lower respiratory tract (URT/LRT) affections.
Method A double-blind, rando… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.